Manuel Martín-Lomas
Corporate Officer/Principal at Consejo Superior de Investigaciones Científicas
Profile
Manuel Martín-Lomas is currently the Scientific Director at Centro de Investigacion Cooperativa en Biomateriales and the Vice President at Consejo Superior de Investigaciones Científicas.
Previously, he served as the Chairman at European Carbohydrate Organization in 1997 and was a Member-Scientific Advisory Board at Metabolic Renal Disease SL.
Dr. Martín-Lomas holds a doctorate degree from the University of Seville.
Manuel Martín-Lomas active positions
| Companies | Position | Start |
|---|---|---|
| Consejo Superior de Investigaciones Científicas | Corporate Officer/Principal | 2009-10-07 |
| Centro de Investigacion Cooperativa en Biomateriales | Corporate Officer/Principal | - |
Former positions of Manuel Martín-Lomas
| Companies | Position | End |
|---|---|---|
| European Carbohydrate Organization | Chairman | 1996-12-31 |
Metabolic Renal Disease SL
 Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Director/Board Member | 2012-10-04 |
Training of Manuel Martín-Lomas
| University of Seville | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Metabolic Renal Disease SL
Metabolic Renal Disease SL Medical SpecialtiesHealth Technology Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain. | Health Technology |
| European Carbohydrate Organization | |
| Centro de Investigacion Cooperativa en Biomateriales |
- Stock Market
- Insiders
- Manuel Martín-Lomas
